An open clinical pilot study of the efficacy and safety of oral terbinafine in dry non-inflammatory tinea capitis
- 1 February 1992
- journal article
- Published by Oxford University Press (OUP) in British Journal of Dermatology
- Vol. 126 (s39) , 47-50
- https://doi.org/10.1111/j.1365-2133.1992.tb00010.x
Abstract
Ten patients with dry non-inflammatory tinea capitis were evaluated in a pilot study which ran from September 1989 to February 1990. Each patient was given oral terbinafine for 6 weeks; each was followed up 2 weeks later. Eight (80%) were completely cured, one (10%) was mycologically cured and showed minimal signs and symptoms, and another (10%) showed improvement (negative mycology, but persistent clinical signs and symptoms). No topical or systemic side-effects were noted. Terbinafine appears to be an effective and safe antifungal agent in the treatment of non-inflammatory tinea capitis.Keywords
This publication has 6 references indexed in Scilit:
- Present status of the efficacy and tolerability of terbinafine (Lamisil) used systemically in the treatment of dermatomycoses of skin and nailsJournal of Dermatological Treatment, 1990
- Allylamines — Mode and selectivity of action compared to azole antifungals and biological fate in mammalian organismsJournal of Dermatological Treatment, 1990
- The early development of allylamine antimycoticsJournal of Dermatological Treatment, 1990
- In vitro activity of terbinafineClinical and Experimental Dermatology, 1989
- The mechanism of action of terbinafineClinical and Experimental Dermatology, 1989
- Oral ketoconazole as an alternative to griseofulvin in recalcitrant dermatophyte infections and onychomycosisActa Dermato-Venereologica, 1985